INTRODUCTION {#sec1-1}
============

The incidence of postoperative atrial fibrillation (POAF) ranges between 10% and 65%.\[[@ref1]\],\[[@ref2]\] in cardiac surgical patients. This is associated with increased rate of postoperative complications such as congestive heart failure, renal insufficiency, thromboembolic events and stroke, which prolong the length of hospital stay, increase rates of rehospitalisation and the overall cost of hospitalisation.\[[@ref3]\] Postoperative delirium and neurocognitive decline have also been associated with it.\[[@ref4]\] Myocardial ischemia and inadequate cardioplegic protection of the atria increase the incidence of POAF.\[[@ref5]\]

The aim of this study was to evaluate the incidence and risk factors of POAF after cardiac surgery under cardiopulmonary bypass (CPB).

METHODS {#sec1-2}
=======

After obtaining approval from the Ethics Committee, we included 150 adult patients undergoing coronary artery bypass graft (CABG) and valvular surgery using cardiopulmonary bypass (CPB) over a period of 1 year. Data were collected prospectively from cardiovascular surgery operation theatre and intensive care unit (ICU) for this observational descriptive study. Patients with chronic AF and those undergoing cardiac surgeries other than CABG and valve replacement were excluded. Since no similar studies were conducted in the past in this institute, the sample size was calculated based on the cardiac surgical workload of the hospital.

The predictors of POAF which were studied include preoperative parameters such as age \>60 years, left ventricular ejection fraction (LVEF) \<40%, prior diabetes (fasting plasma glucose level 126 mg/dL or random plasma glucose greater than 200 mg/dLor patient on chronic antidiabetic treatment), prior myocardial infarction (MI), chronic obstructive pulmonary disease and use of beta blocker therapy. Intraoperative parameters included were type of surgery (valvular or CABG), aortic cross clamp time \>60 min and CPB time \>100 min. Duration of postoperative inotropic support \>30 min and postoperative ventilatory support \>24 h were also considered.

The outcome was POAF which was documented from detection of AF on the lead II of cardioscope and was correlated with the risk factors. The length of hospital stay and mortality were also studied.

A binomial logistic regression was performed to predict the association of multiple risk factors contributing to AF. Both unadjusted and adjusted odds ratios are reported. IBM SPSS Statistics V.13 and Microsoft Excel were used for analysis and graphical representation, respectively.

RESULTS {#sec1-3}
=======

The mean age of the patients was 46.7 years with a standard deviation of 13.3 years, and the male-to-female ratio was 70:80. The incidence of POAF in the study group was 40.7%.(61 patients)

Tables [1](#T1){ref-type="table"}--[3](#T3){ref-type="table"} show the distribution of risk factors and the association of AF with the risk factors, respectively. Non-use of β blockers preoperatively was associated with lower odds of developing atrial fibrillation (OR 0.153) and the association is significant (*P* value: 0.004). Patients with LVEF \>/=40% had lower odds of developing atrial fibrillation \[OR 0.174; 95% confidence interval (CI) 0.032-0.952\] and the association is significant (*P* = 0.04). Also, those patients who did not require inotropic support for more than 30 minutes postoperatively had lower odds of developing atrial fibrillation (OR 0.127; 95% CI 0.028-0.576)) and the association is highly significant (*P* = 0.007).

###### 

Distribution of risk factors among the study groups
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###### 

Incidence of POAF in pts with various risk factors
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###### 

Multivariate analysis showing association of postoperative atrial fibrillation with risk factors
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The odds of having AF were 6.27 times higher among those with prior MI (*P* = 0.04). Also the odds of having AF were 12.28 times higher in those in whom ventilator support was present for more than 24 h (*P* = 0.023).

Tables [4](#T4){ref-type="table"} and [5](#T5){ref-type="table"} show the distribution of patients developing AF at various timelines and the association of AF with increased hospital stay and mortality, respectively.

###### 

Time of occurrence of postoperative atrial fibrillation among study subjects
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###### 

Association of increased hospital stay and mortality with POAF in subjects
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DISCUSSION {#sec1-4}
==========

POAF remains a frequent complication of CABG and valvular surgeries. We found that the majority of the initial episodes of AF occurred within the first 3 days after cardiac surgery with peak incidence on the second postoperative day. Aranki *et al*. and Funk *et al*. also endorsed similar findings.\[[@ref5]\],\[[@ref6]\]

Proposed mechanisms such as pericardial inflammation, autonomic imbalance during the postoperative period, excessive production of catecholamines and a fluid shift with resultant changes in volume and pressure are all contributory to the development of POAF.\[[@ref7]\],\[[@ref8]\]

The danger of AF is related to the rapid heart rate, irregular rhythm, loss of atrial kick and risk of atrial thrombosis. These can be treated by electrical or pharmacological conversion from AF to sinus rhythm followed by antiarrhythmic medication to maintain sinus rhythm. Alternatively, rate control and anticoagulation without conversion to sinus rhythm can be used.\[[@ref9]\]

Advanced age has been the most consistent predictor of POAF.\[[@ref10]\] In a study done by Mathew *et al*.,\[[@ref4]\] it was found that every 10-year increase in age is associated with a 75% increase in the odds of developing AF. Thus, on the basis of age alone, anyone older than 70 years is considered to be at high risk for developing AF. However, in our study the incidence of POAF was more in valvular surgical patients, and since these patients were younger in age there was a preponderance of incidence in the younger age group \[[Table 2](#T2){ref-type="table"}\]. This was coupled by the fact that CABG patients presented at younger age group in our institution.

In our study, previous history of MI was strongly associated with development of POAF although diabetes was not. In 1996, Aranki *et al*.\[[@ref5]\] found that patients with previous history of MI are at greater risk of POAF after cardiac surgery. Mueller *et al*.\[[@ref8]\] studiedAF and minimally invasive CABG and found that diabetes was strongly associated with development of POAF. Since our study had a mixed population with a large number of valvular surgical patients who were younger, we did not find a significant correlation between the two.

In studies by Zaman *et al*. and Yi-Ting Tsai *et al*., there was a significantly lower incidence of POAF in patients on β-blockers.\[[@ref9]\],\[[@ref10]\] Sympathetic activation or an exaggerated response to adrenergic stimulation may be an important trigger for POAF.\[[@ref11]\] Therefore, β-blockers, by antagonising the sympathetic activity, serve to protect against it. In our study there was a definite association between those patients not taking β-blockers and the development of atrial fibrillation (OR -0.153). However we could not directly prove the protective effect of β-blockers.

LVEF \<40%in the preoperative period was strongly associated with development of POAF (*P* \< 0.005). Valve surgery and CABG surgery are associated with an increased risk of AF. Although the incidence of AF after valve surgery was more than that in patients undergoing CABG surgery in our study, statistical tests showed no significant difference in the incidence of POAF in between valvular surgery and CABG surgery \[[Table 2](#T2){ref-type="table"}\]. Almassi *et al*. studied AF after cardiac surgery and found that incidence of POAF was 27.5% after CABG, 48.8%after mitral valve replacement (MVR), 32.9% after aortic valve replacement (AVR), 36.4% after CABG + AVR and the maximum incidence was 60% following CABG + MVR.\[[@ref12]\] The possible explanation could be a result of structural and hemodynamic abnormalities such as left atrial enlargement, pathological changes from rheumatic heart disease, increased left atrial pressure and surgical trauma.

It was seen from our study that patients who underwent cardiac surgery with prolonged aortic cross clamp time (\>60 min) and CPB time(\>100 min) had higher incidence of POAF (*P* \< 0.001). Helgadottir *et al*. and Hashemzadeh *et al*. also noted similar findings.\[[@ref13]\],\[[@ref14]\] CPB is associated with an ischemia-reperfusion injury inducing a complex inflammatory response, the analogous of which have been reported in patients with AF. These range from the presence of inflammatory infiltrates in atrial biopsies to increased concentrations of C-reactive protein which form the substrate for generation of ectopic activity.\[[@ref15]\],\[[@ref16]\]

The need for using inotropic agents in the postoperative period is related to two major factors: the preoperative degree of myocardial dysfunction and intraoperative events such as inadequate myocardial protection, incomplete revascularisation and technical difficulties. Our data show that if inotropic support was needed beyond 30 mins after termination of CPB, although the difference was not statistically significant, the incidence of AF was higher than those who required it for \<30 min. Hashemzadeh *et al*. in their study on POAF following open cardiac surgery found that post-CPB inotropic support for \>30 min was the single most important postsurgical predictor of POAF.\[[@ref13]\]

When extended ventilation was needed in the postoperative period, in our patients, it was associated with increased incidence of POAF. Aranki *et al*. in their study have documented these findings.\[[@ref5]\] Causative agents may be hypoxia, hypovolemia, sepsis and electrolyte imbalances.\[[@ref17]\]

In our study, patients with AF had a longer median stay in the ICU \>3 days in comparison to patients in sinus rhythm who got discharged on the third day. This may be related to the need for stabilisation of hemodynamic status, correction of hypoxia, need for ventilatory support or a combination of all. Other authors like Creswell *et al*. and Aranki *et al*. have found similar association.\[[@ref8]\],\[[@ref3]\] The increase in the cost of hospitalisation makes it imperative to design strategies to prevent the occurrence of AF, to treat it effectively once it develops and to initiate prophylactic anticoagulation protocols for prevention of embolic strokes. AF increased the median postoperative hospital stay from 7 days in patients in sinus rhythm to \>7 days in those who developed POAF. Although we did not analyze the actual hospital costs per patient, it is clear that an increase in hospital stay will significantly drive up the cost of hospitalisation. Above all, there was an increased mortality also because of POAF than mortality because of other cause (4% vs 1.33%). Almassi *et al*. found the incidence of POAF to be 29.6% and the in-hospital mortality was 6% after surgery, for patient with POAF when compared with 3% for patients with no POAF (*P* \< 0.002).\[[@ref10]\]

Most of these patients would revert to sinus rhythm within 6 weeks, and electrical cardioversion could be done on an outpatient basis for the few patients who do not revert despite pharmacological treatment.\[[@ref17]\] Such an approach would result in a considerable reduction in length of stay in hospital and significant cost reduction.

The limitations of our study were that both CABG and valve surgeries were included. In addition, the sample size was not calculated and arbitrarily chosen on the basis of our workload. The cost burden on those patients could also not be calculated.

CONCLUSION {#sec1-5}
==========

The peak incidence of POAF after cardiac surgery was on the second postoperative day with the incidence being 40.7% in our study. A low preoperative EF (\<0.4%), prior MI, CPB time \>100 min and extended ventilation for \>24 h showed a significant association with POAF. It also increased hospital stay and mortality in study subjects.
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